Odd-skipped genes encode zinc-finger transcription factors with widespread roles in embryonic development. In Drosophila, oddskipped acts as a pair-rule gene, while its orthologous gene in Caenorhabditis elegans is involved in gut development. In mammals two paralogs exist, Osr1 and Osr2, with functions described in heart and urogenital, and in secondary palate development, respectively. As the chicken embryo is a widely used system for analysing gene function in vivo, we determined the expression pattern of the two chicken orthologues, cOsr1 and cOsr2, during embryonic development. We demonstrate expression of both genes in a variety of organs and structures, such as kidney, eye, branchial arches and dermis. Both genes show a highly dynamic expression pattern with partially overlapping, but mostly distinct domains of expression. Special emphasis in this study was laid on the investigation of cOsr1 and cOsr2 in limb development, where we compared their expression pattern with the expression of Osr1 and Osr2 in the mouse.
Results and discussion
In Drosophila, odd-skipped (odd) is part of a small gene family encoding C2H2 zinc-finger transcription factors. Odd was initially characterised as a pair-rule gene. Mutations in odd cause the loss of odd-numbered segments (Nusslein-Volhard and Wieschaus, 1980; Coulter and Wieschaus, 1988) . In this context, Odd can function either as a repressor or activator of target gene transcription (Saulier-Le Drean et al., 1998) . Beyond its function during segmentation, odd is expressed in several tissues during Drosophila embryogenesis (Ward and Coulter, 2000) , including the gut, nephrocytes, the nervous system and pericardial cells (Ward and Skeath, 2000) .
Odd homologous genes have been cloned and characterised from several other species, including Caenorhabditis elegans (Buckley et al., 2004) , mouse (So and Danielian, 1999; Lan et al., 2001 ) and man (Debeer et al., 2002; Katoh, 2002) .
In mammals, two odd-skipped related genes exist, Osr1 and Osr2. Both genes exhibit a dynamic expression pattern during mouse embryogenesis, showing predominant expression in intermediate mesoderm, branchial arches, kidneys and limbs (So and Danielian, 1999; Lan et al., 2001) . Functionally, Osr1 and Osr2 have been characterised in the mouse by gene targeting. Mice with inactivated alleles of Osr1 show severe defects in embryonic heart and kidney development and die in utero (Wang et al., 2005) . Osr2 null mice on the other hand show specific defects in secondary palate development (Lan et al., 2004) .
In the chick, it is so far only known that cOsr1 is an early marker of the intermediate mesoderm showing expression laterally of the somites as early as Hamburger-Hamilton (HH) stage 10 (James and Schultheiss, 2005) . No chicken orthologous gene for Osr2 has been described to date. As the chicken is a powerful and widely used developmental model organism, we determined the expression pattern of the chicken orthologous genes cOsr1 and cOsr2 during embryonic development. Special emphasis was laid on embryonic limb development, where we compared the expression of cOsr1 and -2 to their mouse orthologues, for which no detailed limb expression pattern has been described so far.
We have used the BBSRC chicken EST database (Boardman et al., 2002) to identify ESTs containing partial sequences of chicken Osr genes. Two ESTs for cOsr1 matching the predicted coding sequence (XM_419967) were found and used for hybridisation. Both ESTs yielded identical results. For cOsr2, no ESTs were identified. We used the predicted sequence for chicken Osr2 (XM_418353) as a template to generate specific probes. Two independent probes were used harbouring 5 0 -coding sequence without the zinc-finger coding region, or complete coding sequence. Both probes showed identical hybridisation signals.
In the early chick embryo, the expression of cOsr1 is associated with the lateral mesoderm. We found first expression of cOsr1 at HH6 in a medial domain at both sides of the neural fold (Fig. 1A) . cOsr1 shows no expression in the posterior part of the embryo, which is still undergoing gastrulation. During further development (HH8-10) the medial domain of cOsr1 expression expands caudally, as the primitive streak regresses. cOsr2 could first be detected at HH8 in a faint expression domain surrounding the outer margin of the area pellucida (Fig. 1B) . This expression can still be seen at HH10, where cOsr2 is also expressed in the anterior intestinal portal. At HH13, cOsr1 shows strong expression lateral to neural tube and somites, thereby its expression domain is widening caudally (Fig. 1C ). Vibratome sections demonstrate expression of cOsr1 in intermediate mesoderm (IM) and lateral plate mesoderm (LPM). cOsr2 on the other hand appears strongly expressed in the anterior part of the embryo (Fig. 1D) . Sections reveal expression of cOsr2 in the endoderm and, more anteriorly, also in the splanchnic mesoderm. At HH16, cOsr1 expression is found in the IM and LPM in the posterior half of the embryo (Fig. 1E) . The expression of cOsr2 is weak at HH16, but still can be seen in a ventral view of the embryo (Fig. 1F , ventral view in inset). Sections show expression of cOsr2 in the endoderm. Anteriorly, cOsr2 becomes restricted to gut endoderm. Strong expression of cOsr2 can be seen in the developing foregut (Fig. 1F, arrow) , an expression that can still be seen at HH19 (Fig. 2B , arrow, and magnification in Fig. 2I ). Expression of cOsr2 later can also be found in other regions of the intestinal tract. Fig. 2F demonstrates expression in the developing caeca (yellow arrowhead) and the intestine (black arrowhead) at HH24. Vibratome sections reveal that cOsr2 is expressed in superficial mesenchymal layers in both horns of the caecal branches (Fig. 2J ) and in the epithelium of the intestine (Fig. 2K) . In Fig. 2F expression of cOsr2 cannot be seen in the hindgut. Interestingly, the endoderm of the presumptive hindgut region is also negative for cOsr2 in earlier stages (not shown). Expression of odd-skipped genes in the intestinal tract appears to be an evolutionary conserved property, as expression in the gut was also demonstrated in C. elegans (Buckley et al., 2004) and in Drosophila (Ward and Coulter, 2000) .
At HH19, both genes show expression associated with the developing mesonephros. While cOsr1 is strongly expressed in a continuous domain, cOsr2 shows a dotted pattern of expression, which also can be seen at HH22 (Figs. 2A-D, arrowheads) . At HH24, we found expression of cOsr1 in mesenchymal cells surrounding the mesonephric tubules ( Fig. 2E and E 0 ), while cOsr2 is expressed within the tubular cells ( Fig. 2F and F 0 ). Interestingly, first detection of cOsr2 in mesonephric tubules at HH19 apparently coincides with the time at which the mesonephric system starts to remove nitrogenous waste from the blood flow (Schoenwolf, 1995) . It is known that the intermediate mesoderm cells give rise to all kidney tissues (Sainio and Raatikainen-Ahokas, 1999) . Osr1 is known to be one of the earliest markers for intermediate mesoderm in the mouse and also in the chick (Wilm et al., 2004; James and Schultheiss, 2005) . Additionally, in Osr1-deficient mice kidney development is blocked in early stages (Wang et al., Fig. 2 . Expression of cOsr1 and cOsr2 in kidney, craniofacial, gut and heart development. At HH19 (A,B), cOsr1 and -2 are expressed in the mesonephros (black arrowheads). Note expression of cOsr2 in nephric tubules (see ventral view inset). cOsr1 is expressed in the sinus venosus (white arrow, also compare (L)). cOsr2 is expressed in branchial arches II-IV (white arrowheads). Additionally, cOsr2 is expressed in a domain posterior of the eye (red arrowhead). At HH22 (C,D), cOsr1 and -2 are expressed in the mesonephros (black arrowheads) and the limbs. cOsr1 now also shows expression posterior and ventral of the eye (red arrowhead) and is expressed in mesenchyme surrounding the branchial arches caudally (yellow arrowhead). cOsr2 is expressed in all branchial arches, while cOsr1 shows expression in the mandibular process only (white arrowheads). Additionally, cOsr2 can be detected overlapping with anterior somites (arrows). (E,F) Expression of cOsr1 and -2 in the mesonephros at HH24. While cOsr1 is expressed in a continuous domain, cOsr2 is restricted to nephric tubules. Frontal vibratome sections (E 0 ,F 0 ) demonstrate expression of cOsr1 in mesenchyme surrounding the nephric tubules, while cOsr2 is expressed in the tubules. Additional expression of cOsr2 (F) is seen in the intestine (black arrowhead) and in the caeca (yellow arrowhead). (G,H) and (G 0 ,H 0 ) Craniofacial expression of cOsr1 and -2 in frontal and lateral views of HH24 embryos. cOsr1 is expressed in maxillary and mandibular processes, at the tip of the hyoid and the basis of arches III and IV. Strong expression is also seen ventrolateral of the eye (asterisk). cOsr2 is expressed in maxillar and mandibular processes and in medial domains of arches II-IV. Vibratome sections (G 00 ,H 00 ) show coexpression of cOsr1 and -2 in maxillary and mandibular processes (black arrowheads), but separate domains in the hyoid (arrows). Expression in mesenchyme dorsal and caudal of the branchial arches can be seen for both genes (G 0 ,H 0 , dotted arrows), but expression of cOsr2 is restricted to superficial layers as compared to cOsr1 (G 00 ,H 00 , dotted arrows). Expression of cOsr2 is associated with the intestinal tract; (I) expression in the foregut at HH19. (J,K) Vibratome sections as indicated in (F) reveal expression of cOsr2 in superficial cells of caecal buds and in intestinal epithelium, respectively. Expression of cOsr1 is associated with the developing heart. (L) Expression of cOsr1 in the sinus venosus at HH19, (M) expression of cOsr1 in the sinus venosus and in patches on the foregut. At, atrium; fg, foregut; hy, hyoid arch; md, mandibular process; mx, maxillar process; sv, sinus venosus; ve, ventricle. c 2005). However, Osr2-deficient mice show no kidney abnormalities (Lan et al., 2004) .
Osr1-null mice additionally show severe heart defects (Wang et al., 2005) . As in the mouse, we found Osr1 expressed during chick heart development. At HH19, cOsr1 is expressed in the sinus venosus of the developing heart ( Fig. 2A , white arrow; magnification in Fig. 2L ). At HH22, there is still apparent strong expression in the sinus venosus, additionally patches of positive staining can be seen in the foregut (Fig. 2M) .
From HH19 on, cOsr2 is expressed in the branchial arches II-IV (Fig. 2B, white arrowheads) . cOsr1 is not expressed in the branchial arches at this stage. At HH22, cOsr2 is strongly expressed in all four branchial arches (Fig. 2D, white arrowheads) , while cOsr1 shows high expression in the maxillary and mandibulary processes Fig. 3 . Expression of cOsr1 and cOsr2 in trunk dermis compared to muscle markers cMyoD and cPax3. At HH24 (A,B), expression of cOsr2 is intensified overlapping with the somites at forelimb level, while cOsr1 is strongly expressed in the flank caudal of the cOsr2-domain (arrows). Spatially separated expression of cOsr1 and cOsr2 in the body flank is maintained at HH28 (C,D), where cOsr1 is expressed in a lateral domain (arrow), while cOsr2 is expressed dorsally (arrows). (E,J) Overview of cOsr1 and cOsr2 expression in the body flank with vibratome section orientation indicated by broken lines. Vibratome sections show staining for cOsr1 (G,I), cOsr2 (L,N) and cMyoD (F, H, K, and M). Anterio-posterior extension of myotome is indicated by arrows in (F) and (K). Note stronger staining for cOsr1 and cOsr2 at intersomite level (arrows in (G) and (L)). (I,N) Transverse sections showing cOsr1 and cOsr2 expression in the dermis lateral to the myotome. Note that ventral expansions of cOsr1 and cOsr2 domains coincide with the ventral expansion of cMyoD staining. (O-T) Two-colour fluorescent in situ hybridisations with cOsr1 and cPax3 or cMyoD, respectively. Note that cOsr1 is expressed in a broad domain, where cells expressing cOsr1 intermingle with premyogenic cells expressing cPax3. Coexpression of cOsr1 and cPax3 or cMyoD is not observed. (U-W) Costaining of cOsr1 and myosin heavy chain (MHC) demonstrates no expression of cOsr1 in myocytes. (X-Z) cOsr2 is expressed in a more superficial domain exhibiting no contact with myogenic cells. CPax3 and cMyoD are shown for comparison. At HH22, cOsr1 and cOsr2 are expressed in partially overlapping domains. Thereby, cOsr1 expression partially overlaps with the region of muscle differentiation marked by cMyoD (arrowheads), while the expression of cOsr2 overlaps with part of the cPax3 domain. Note coincidence of the distal expansion of cOsr1 and cOsr2 expression at HH24 with cMyoD and cPax3 expression, respectively. At HH26, expression domains of cOsr1 and cOsr2 split; cOsr1 is expressed in mesenchyme surrounding the premuscle masses distally (arrows), cOsr2 is still expressed overlapping with cPax3 and cMyoD. At HH28, separation of cOsr1 and cOsr2 domains can still be seen. In the autopod, cOsr1 shows expression in interdigital mesenchyme (arrowheads) while cOsr2 is expressed overlapping with condensations. (B) Analysis of Osr1 and Osr2 limb expression in the mouse. Forelimbs (FL) and hindlimbs (HL) of 11.5-and 12.5-day embryos are shown. Note partially overlapping expression of mOsr1 and mOsr2 in a medial domain in E11.5 fore-and hindlimbs. In E12.5 limbs, expression domains of mOsr1 and mOsr2 have split comparable to the situation in the chick at HH26. Note expression of mOsr1 in interdigital mesenchyme (arrowheads) and expression of mOsr2 overlapping digit condensations. (C) Longitudinal vibratome sections of chick and mouse limbs stained for Osr1 or Osr2 at stages indicated. Sections reveal expression of both, Osr1 and Osr2, in chick and mouse in superficial domains dorsal and ventral of the premuscle masses. Comparison of chick and mouse expression patterns shows a high degree of similarity between both species. Note that mOsr2 in the E11.5 hindlimb is lacking the proximal domain present in the chick hindlimb at HH24 (arrows; also compare with (B)). At HH25, there is remarkable coexpression of cOsr1 and -2 in the proximal domain. The distal expression domains of Osr1 and -2 start to separate in the chick hindlimb at this developmental stage. This is also observed in the mouse E11.5 FL (red arrows). At HH27, Osr1 and Osr2 appear to be mutually exclusive in distal regions in chick and mouse (red arrows). Coexpression is still seen in the proximal domain in the chick (black arrows). c (Fig. 2C , white arrowhead) but is not expressed in arches II-IV. Additionally, cOsr1 is expressed in mesenchyme surrounding the branchial arches caudally (Fig. 1C, yellow  arrowhead) . From HH24 on, both genes are robustly expressed in all branchial arches (Figs. 2G and H) . Strong expression of cOsr1 is seen in the maxillary and mandibular processes. Weaker expression is seen at the tip of the hyoid (II) and at the base of arches III and IV ( Fig. 2G and G 0 ).
In the maxillary and mandibulary processes, cOsr2 shows expression in a domain reminiscent of the cOsr1 expression ( Fig. 2H and H 0 ). In arches II-IV cOsr2 is expressed in medial areas, thereby appearing mutually exclusive with cOsr1 ( Fig. 2G and G 0 , and H and H 0 ). This is also demonstrated on frontal vibratome sections, where overlapping staining can be seen in the maxillary and mandibular processes (Fig. 2G 00 and H 00 , arrowheads), but exclusive expression is seen in the hyoid arch (Figs. 2G 00 and H 00 , arrows). cOsr1 and cOsr2 are also expressed in mesenchymal cells flanking the basis of the branchial arches (Figs. 2G 0 and H 0 , dotted arrows), where cOsr1 shows a more widespread expression than cOsr2. Vibratome sections show that cOsr2 is expressed mainly in most superficial mesenchymal cell layers, while the expression of cOsr1 comprises deeper cell layers. As in the caudal branchial arches, both genes appear mutually exclusive in this expression domain (compare Figs. 2G 00 and H 00 , dotted arrows). Both genes also show expression associated with the developing eye. At HH24, cOsr1 is expressed in a domain at the caudal side of the eye; this domain is negative for cOsr2, which is expressed in a layer of mesenchymal cells surrounding almost the whole eye (Figs. 2G 0 and H 0 , asterisks). Expression associated with the eye can be seen from HH22 on for cOsr1 (Fig. 2C, red arrowhead) , and from HH19 on for cOsr2 (Fig. 2B, red arrowhead) .
At HH24, both genes are expressed overlapping with the developing somites at the flank of the embryo. Here, cOsr1 and -2 are expressed in mutually exclusive domains along the anterior-posterior axis of the embryo. While the expression of cOsr1 starts caudally of the forelimbs, cOsr2 is expressed in the flank area at the level of the forelimb with its most caudal domain at the point where the expression of cOsr1 starts (Figs. 3A and B, arrows) . While expression of cOsr1 in the flank starts at HH24, cOsr2 can be detected overlapping with somites cranial of the forelimb already at HH22 (Fig. 2D, arrows) . A mutual exclusive pattern of expression is maintained during further development, with expression of cOsr1 situated at the lateral flank of the somites and expression of cOsr2 at the dorsalmost edges of the somites (Figs. 3C and D, arrows) . Section analysis revealed expression of cOsr1 in the dermis lateral to the myotome marked by cMyoD, stronger expression is seen between somites than adjacent to somites (Figs. 3F and G) . Transverse sections at interlimb level show the ventral expansion of the cOsr1 expression domain overlapping with the extension of cMyoD positive myoblasts (Figs. 3H and I) . Thus, cOsr1 appears to be expressed in intimate contact with myotomal cells. To see, whether cOsr1 is expressed in different types of myotomal cells, we performed two-colour fluorescence-labelled in situ hybridisation on transverse sections. Hybridisations demonstrate that cOsr1 expressing cells are in close spatial contact and even intermingling with the cPax3 positive myogenic precursors (Figs. 3O-Q) . Double labelling for cOsr1 and cMyoD shows no expression of cOsr1 in committed myogenic precursors (Figs. 3R-T) . Costaining for cOsr1 and myosin heavy chain (MHC) demonstrates that cOsr1 is not expressed in differentiated myocytes (Figs. 3U-W) .
Section analysis performed in the region of cOsr2 expression (i.e., the somites at forelimb level) revealed a pattern of expression partially similar to that of cOsr1 flanking the caudal somites. Frontal sections show that cOsr2 is expressed in the dermis lateral to the myotome, but apparently in a more superficial domain than it was seen for cOsr1 (Figs. 3K and L) . Transverse sections show that the ventral expansion of the cOsr2 domain also overlaps with the ventral expansion of the myotome labelled by cMyoD, as it was the case for cOsr1 (Figs. 3M and N) . Concordant with the superficial expression seen in the vibratome sections, cOsr2 expressing cells show less close spatial contact to Pax3 expressing cells than it was the case for cOsr1. Two-colour fluorescence-labelled in situ hybridisation (Figs. 3X-Z) demonstrates expression of cOsr2 in a superficial layer of cells clearly separated from the Pax3 expressing myogenic precursors.
From HH22 on, strong expression of both cOsr1 and -2 can be seen in the developing limbs. Fig. 4A shows expression of cOsr1 and -2 in developing chick hindlimbs. As we found a close spatial conjunction between the expression of cOsr genes and muscle development related genes in the trunk, we compared the limb expression patterns of cOsr1 and -2 to the expression of cPax3 and cMyoD, labelling migrating and differentiating muscle cells of the limb premuscle masses. Hindlimbs have been chosen for the expression analysis, as they are anatomically more related to mammalian limbs than the forelimbs, which give rise to the highly specialised structures of the wing. Generally, vertebrate limb development starts with the outgrowth of tissue from the lateral plate mesoderm forming the limb bud. The nascent limb bud mainly consists of two different types of cells, undifferentiated mesenchymal cells and ectodermal cells covering the bud. Early thereafter, the tissues that will later form all components of the limb start to differentiate. While cartilage, tendons and connective tissue arise within the limb from mesenchymal cells derived from lateral plate mesoderm, the cells forming muscles and blood vessels migrate into the limb bud from the somites (Chevallier et al., 1977; Christ and Brand-Saberi, 2002; Akiyama et al., 2005) .
Expression of cOsr1 can be traced at HH22 in the posterior mesenchyme and in the medial portion of the chick hindlimb bud, while cOsr2 is expressed in a broad, medially located domain in the limb mesenchyme (Fig. 4A) . Interestingly, the medial part of the cOsr1 expression domain shows spatial overlap with the differentiating premuscle cells labelled by cMyoD (Fig. 4A, arrowheads) . The cOsr2 expression resembles the domain of cPax3 positive migrating and proliferating cells, however, it encompasses a smaller domain than cPax3. At HH24, there is strong expression of cOsr1 surrounding the limb basis. The domain in the middle of the limb has expanded distally. cOsr2 shows weaker expression at the limb basis, but intense staining can be seen in its distal portion. This distal expression domain, which is shared by both genes, shows considerable spatial overlap with migrating (cPax3) and for cOsr1 especially differentiating muscle precursors (cMyoD). As in HH22 hindlimbs, the domain of cOsr2 expression is broader than that of cOsr1. At HH26, the initial coexpression of cOsr1 and -2 undergoes dramatic change. The expression domains of both genes split and become mutually exclusive, with the exception of the limb basis. The cOsr1 domain has expanded and is now distally surrounding the expression domains of cPax3 and cMyoD (arrows). Contrasting to this, cOsr2 remains expressed in the domain overlapping with the migrating/differentiating muscle. At HH28, the cOsr1-domain surrounding the distal margin of the premuscle mass can still be seen, while cOsr2 expression remains associated with the developing muscles. In the autopod, cOsr1 is now expressed in interdigital regions (arrowheads), while the expression of cOsr2 is confined to mesenchymal areas overlapping with the digit condensations.
The embryonic limb is a well-characterised developmental model system for the investigation of patterning, tissue specification and differentiation. To evaluate the evolutionary conservation of odd-skipped gene expression in vertebrate limb development, we re-analysed expression of mOsr1 and -2 in the mouse limb at comparable differentiation stages to those used in the chick. Overall, in the mouse limb, the expression patterns of both genes are highly similar to the chick (Fig. 4B) . For days 11.5 and 12.5 fore-and hindlimbs are shown, as the development of the hindlimb is lagging behind the development of the forelimb, thus both represent different phases of limb development. At E11.5, expression of mOsr1 in fore-and hindlimb is comparable to the chick hindlimb at HH24 and 25 (latter not shown), with expression at the limb basis and also in the medial part. Osr2 in the mouse is also strongly expressed in a medial domain in the limb mesenchyme, which is overlapping the medial domain of mOsr1 expression. However, the domain of Osr2 expression surrounding the limb basis present in the chick is lacking in the mouse. At E12.5, expression of mOsr1 in the hindlimb still resembles the pattern observed in the chick at HH26, showing expression at the limb base and distally coinciding with muscle migration/differentiation. However, the characteristic domain of cOsr1 expression surrounding the premuscle mass distally cannot be seen in the mouse. As in the chick, at this stage the expression domains of mOsr1 and -2 split and apparently exclude each other. As observed in the chick between HH26 and 28, autopod expression of mOsr1 is also confined to the interdigital spaces in the E12.5 hind-and forelimbs (arrowheads), while mOsr2 is expressed overlapping with digit condensations.
To refine the relationship between Osr1 and Osr2 in chick and mouse, we compared vibratome sections of corresponding developmental stages. Chick HH24 hindlimb was compared to mouse E11.5 hindlimb, chick HH25 hindlimb to mouse E11.5 forelimb and chick HH27 hindlimb to mouse E12.5 hindlimb (Fig. 4C) . At HH24, cOsr1 is expressed in superficial cell layers in the dorsal and ventral mesenchyme of the chick leg bud. A highly similar pattern can be seen in the mouse leg bud. As suggested by the whole-mount ISH, at this stage cOsr2 shows an expression pattern largely overlapping with that of cOsr1, while in the mouse expression can be seen only in a domain overlapping with the distalmost expansion of the Osr1 domain. In both species, the expression domains of Osr2 appear to extend more distally than those of Osr1. At HH25/E11.5 (forelimb), the beginning subdivision of expression domains of Osr1 and Osr2 in chick and mouse already becomes apparent by section analysis. While in the proximal mesenchyme, cOsr1 and -2 are still coexpressed in superficial cell layers (black arrows), in the distal portions of their expression Osr1 and Osr2 in chick and mouse appear to occupy at least in part different domains of mesenchymal cells (red arrows). At HH27/ E12.5 (hindlimb), separation of Osr1 and -2 domains has advanced in both species, with exception of the proximal area in the chick (black arrows). In distal areas, almost complete exclusive expression of Osr1 and Osr2 can be observed in limb mesenchyme in chick and mouse (red arrows).
To analyse the expression of Osr genes in later limb development, we performed section ISH analysis on chicken HH35 hindlimbs and mouse E13.5 forelimbs. Osr1 is continuously expressed in interdigital mesenchyme in chick and mouse (Figs. 5A and C, arrowheads) . Furthermore, it is revealed that both genes in chick and mouse are Summarising, we identified expression of chicken Osr1 and Osr2 in the developing kidney, heart, gut, eye, branchial arches, the trunk dermis and the limbs. Altogether, these domains of expression appear remarkably conserved between chick and mouse, making the chick embryo an attractive model for further functional studies of Osr genes. Expression of odd-skipped genes in domains shared with non-vertebrates, e.g., in the gut, suggests ancestral as well as newly acquired functions of Osr genes in vertebrates.
Experimental procedures
Whole-mount in situ hybridisation (ISH) was carried out as described previously (Schwabe et al., 2004) . Section ISH using digoxygenin-labelled riboprobes was carried out as described in Seemann et al. (2005) . Radioactive section ISH was carried out as in Stricker et al. (2002) . Fluorescence-labelled two-colour ISH on fresh frozen sections was performed essentially as described by Tylzanowski et al. (2003) . Instead of biotinlabelled probes we used FITC-labelled probes. For detection anti-FITC-POD (Roche 1426346) was used. For tissue permeabilisation, we used proteinase k digestion at 1 lg/ml for 5-8 min.
Immunohistochemistry subsequent to ISH was carried out as follows: slides were washed three times in PBS and then incubated in 3% BSA/0.1% saponin in PBS for 1 h. Primary antibody (anti-myosin heavy chain MY-32, Sigma) was applied at 1:200 in the same solution for 1 h at room temperature. Slides were washed three times in PBS and then secondary antibody (goat anti-mouse coupled to AlexaFluor-488, Molecular Probes) was applied (1:250 in 5% BSA/PBS) for 1 h at room temperature. After three washes in PBS slides were mounted in Fluoromount.
For cOsr1, we used EST clones 812m23 and 3k9 from the BBSRC ChickEST-Database (Boardman et al., 2002) . Both ESTs showed an identical pattern. For cOsr2, two probes were designed based on the predicted sequence XM_418353. We amplified the 5 0 -coding region without the zincfinger domain and the full-length ORF for use as probes, respectively, using the primers cOsr2-F: ATGGGCAGCAAGGCGCTGC; cOsr2-R1: GGTTGGCGAAGTCGAAGCG; and cOsr2-R2: TCAGAAGTCCTG CCGCGGGGT. Both probes were PCR amplified from 5-day whole chicken embryonic cDNA and cloned into pCRII-TOPO (Invitrogen). Both probes yielded identical results.
Probes for mouse Osr1 and Osr2 were made by PCR amplification from E12.5 total cDNA using the primers Osr1-F: TTTCCGGAGGCAA GACCAC; Osr1-R: GGAAGGCCGCACACTCAACTC; Osr2-F: GCA GACATCAAGCCCTACAGCTG; Osr2-R: GAGCCGTGAATATCT ACAAGGATC. All PCR products were cloned into pCRII-TOPO (Invitrogen).
Additional probes used were: cMyoD (Mennerich and Braun, 2001 ) and cPax3 (Goulding et al., 1993) .
